Gamma Ray Sterilization: How It Works and Why Indian Manufacturers Are Switching to It

Author : Akshar Gamma | Published On : 07 Aug 2026

For manufacturers of medical devices, surgical consumables, pharmaceutical packaging and single-use laboratory plastics, sterility is not a feature — it is the entire licence to sell. Yet the method chosen to achieve it quietly decides how much product survives the process, how long it sits in quarantine, and how easily a regulator can be satisfied. This is why gamma ray sterilization has moved from a niche industrial service to a mainstream requirement across India's healthcare manufacturing base. It sterilises a product that is already sealed inside its final packaging, at room temperature, without steam, without ethylene oxide, and without a residue to chase afterwards.

The appeal is straightforward. Heat warps polymers. Chemical sterilants leave residues that must be aerated out and then proven absent. Gamma processing sidesteps both problems, which is exactly why it dominates in categories where the product is heat-sensitive, moisture-sensitive, or simply impossible to open and re-seal once it has left the cleanroom.

What Gamma Ray Sterilization Actually Does

The process uses high-energy photons emitted by a Cobalt-60 source. Product is loaded into totes or carriers, moved through a heavily shielded irradiation cell on a conveyor system, and exposed to the source for a calculated period. The photons pass straight through cartons, blister packs and polymer housings, and as they travel they ionise atoms in their path. That ionisation shatters the DNA of any bacteria, mould, yeast, spore or virus present. The organism cannot replicate, and a non-replicating organism is a dead one for sterility purposes.

Two points matter here and are often misunderstood. First, the product never becomes radioactive — gamma photons do not have the energy to activate the nuclei of the materials they pass through, and the product is safe to handle the moment it leaves the cell. Second, the process is measured in absorbed dose, expressed in kilograys (kGy), not in time or temperature. Dose is what is validated, dose is what is documented, and dose is what an auditor will ask to see.

Why Manufacturers Move Away From Heat and Chemicals

Autoclaving remains excellent for stainless instruments and heat-stable glassware, but it is unusable for the polypropylene, polyethylene and PVC that make up most disposable medical products. Ethylene oxide handles heat-sensitive items well, but it introduces a long aeration cycle, occupational exposure controls, and residue testing on every batch. Both approaches also require the product to be dry, and both struggle with dense or awkwardly shaped loads.

Gamma processing removes those constraints. A sealed carton of pre-filled syringes can be palletised, irradiated, and shipped without ever being opened. Because the treatment is applied to the finished, packaged goods, the sterile barrier is never compromised after the fact — which is precisely the failure mode most likely to trigger a recall. Facilities such as gamma ray sterilization providers operating validated Cobalt-60 plants in India have built their throughput around this reality, handling everything from single cartons for pilot batches to full truckloads for commercial supply.

Which Products Are Suited to the Process

The list is broader than most manufacturers assume. Disposable syringes, IV sets, catheters, surgical gloves, sutures, wound dressings, orthopaedic implants and dental consumables are the obvious candidates. Beyond devices, the process is widely used for pharmaceutical raw materials and excipients, tissue allografts, veterinary products, cosmetic ingredients, herbal and ayurvedic formulations that need microbial load reduction, and laboratory plasticware such as petri dishes and pipette tips.

There are genuine limits. Some polymers — PTFE and certain grades of polypropylene among them — degrade or discolour above particular dose thresholds. Certain drug molecules and biologics are dose-sensitive. Glass can brown. None of these rule the process out automatically; they simply mean material compatibility testing at the intended dose must happen before validation, not after a batch has been ruined. A competent processing partner will insist on this step rather than skip it.

Validation, Dosimetry and Regulatory Compliance

Sterility claims in India are governed by CDSCO under the Medical Devices Rules, and the technical benchmark is ISO 11137, the international standard for radiation sterilisation of health care products. Validation under ISO 11137 means establishing a sterilisation dose that reliably achieves the required sterility assurance level — conventionally an SAL of 10⁻⁶, meaning no more than a one-in-a-million probability of a viable organism surviving on a given unit.

Getting there involves bioburden testing on the incoming product, dose mapping to identify the minimum and maximum dose positions within a loading configuration, verification dose experiments, and then quarterly dose audits to confirm the established dose remains valid as bioburden shifts. Routine dosimeters travel with every load and are read after processing, producing the batch-level record that supports the certificate of sterilisation. Manufacturers exporting to the EU or the United States will find the same standard referenced by notified bodies and the FDA, so a properly validated Indian process transfers directly into overseas dossiers.

Choosing an Irradiation Partner

The technology is mature, so the differences between providers show up in operations rather than physics. Ask about AERB licensing status and the age and activity of the Cobalt-60 source, since a decayed source means longer cycles and slower turnaround. Ask how dose mapping is performed and whether the provider will support your ISO 11137 validation or simply hand you a dose. Ask about turnaround time, because sterilisation sits on the critical path between production and dispatch, and a plant running at capacity will add days to every batch.

Location is worth weighing too. Transporting bulk finished goods across the country to reach a facility adds freight cost, transit risk and days of working capital tied up in stock that cannot yet be invoiced. For manufacturers clustered around Gujarat and western India, a regional plant frequently pays for itself on logistics alone.

Gamma processing is not the right answer for every product, but for sealed, heat-sensitive, high-volume healthcare goods it remains the most practical route to a defensible sterility claim. Manufacturers evaluating the switch, or looking to move existing volumes to a validated facility with faster turnaround, can discuss dose requirements, material compatibility and validation support directly with the technical team at Akshar Gamma.